Cohort | Age of onset of pubertal events | Lung function | Total effect# | Direct effect# | Indirect effect# | |||
Est (95% CI) | p-value | Est (95% CI) | p-value | Est (95% CI) | p-value | |||
IOW | Body hair growth | FVC | 0.15 (0.04–0.25) | 5.77×10−3 | 0.07 (−0.01–0.15) | 0.078 | 0.08 (0.01–0.15) | 0.047 |
Growth spurt | FVC | 0.13 (0.02–0.24) | 0.017 | 0.04 (−0.04–0.12) | 0.282 | 0.09 (0.01–0.17) | 0.034 | |
Facial hair growth | FVC | 0.18 (0.08–0.28) | 5.35×10−4 | 0.09 (0.01–0.16) | 0.026 | 0.09 (0.02–0.16) | 0.014 | |
ALSPAC | Body hair growth¶ | FVC | 0.07 (0.02–0.12) | 0.006 | 0.03 (−0.02–0.08) | 0.219 | 0.04 (0.01–0.07) | 0.003 |
For the IOW, only statistically significant results are included in the table. Est: regression coefficient estimate; FVC: forced vital capacity. #: unit for all the regression coefficients is L·year−1 representing expected lung function change for 1-year increase in pubertal age. ¶: in the IOW cohort, mediation effects were observed for FVC only. Thus, in the replication cohort ALSPAC, only FVC was evaluated. The ages of growth spurt and facial hair growth were not available in ALSPAC. Age at body hair growth is identified by age at attainment of Tanner stage >2 in ALSAPC cohort. Bold indicates statistically significant p-values.